Taking Prenatal Vitamins Yet Still Deficient? Your Genes May Be Blocking Absorption.

MTHFR encodes the enzyme methylenetetrahydrofolate reductase, which converts dietary folate and supplemental folic acid into methylfolate, the active form your cells actually use. This is one of the most critical steps in the methylation cycle, which controls DNA repair, neurotransmitter production, and immune function.

The C677T variant, carried by roughly 40% of women with European ancestry, reduces MTHFR enzyme efficiency by 40 to 70%. Your cells are converting folic acid into active folate at a fraction of the normal rate. Some women with two C677T copies have almost no functional folate conversion capacity, even when eating copious amounts of leafy greens or taking high-dose folic acid.

The result is functional folate deficiency despite normal dietary intake and supplementation. During pregnancy, when folate demands are highest, this deficit becomes critical. You may be taking prenatal vitamins with adequate folic acid and still have inadequate methylfolate reaching your cells. Low folate during pregnancy is linked to neural tube defects, developmental delays, and impaired placental function.

The VDR gene encodes the vitamin D receptor protein, a cellular doorway that allows vitamin D to enter your cells and activate gene expression. Without functional VDR, vitamin D cannot do its job, no matter how much you supplement or expose yourself to sunlight.

Common VDR variants including the FokI, BsmI, and TaqI polymorphisms affect receptor efficiency and cellular responsiveness. Roughly 30 to 50% of the population carry at least one variant that reduces VDR sensitivity. Some VDR variants require 50% more vitamin D supplementation to achieve the same cellular effect as wild-type genotypes. A prenatal vitamin containing the standard 600 to 800 IU of vitamin D may be completely insufficient for women with VDR variants.

During pregnancy, vitamin D controls calcium absorption, immune regulation, and fetal skeletal development. Functional vitamin D deficiency increases risks of preeclampsia, gestational diabetes, and impaired fetal bone mineralization. Women with VDR variants often report feeling vitamin D deficient despite supplementing, and their bloodwork confirms it.

BCMO1 encodes beta-carotene 15,15′-monooxygenase, the enzyme that converts plant-based beta-carotene into retinol, the active form of vitamin A your body uses. If you’re getting vitamin A from orange vegetables, spinach, and other carotenoid sources, BCMO1 is doing the conversion work.

The R267S and A379V variants reduce BCMO1 activity by up to 50% or more. Roughly 45% of the population carries at least one BCMO1 variant. Women with BCMO1 variants may absorb 25% to 50% less vitamin A from dietary and supplemental beta-carotene than those with the normal gene. If your prenatal contains only beta-carotene or relies on plant sources for vitamin A, you may chronically undershoot your vitamin A needs.

Vitamin A is critical for fetal eye development, immune system maturation, and organ development. Low vitamin A during pregnancy increases risks of poor fetal growth and immune compromise. Women with BCMO1 variants often feel better and see better nutrient status when they switch from beta-carotene to preformed retinol.

FADS1 and FADS2 encode fatty acid desaturases, enzymes that convert the plant-based omega-3 precursor ALA (alpha-linolenic acid) into EPA and DHA (eicosapentaenoic and docosahexaenoic acids). DHA is essential for fetal brain development, eye development, and immune function. If your body cannot efficiently convert ALA into DHA, supplementing with flaxseed or chia seeds alone won’t meet your needs.

The rs174537 variant in FADS1 affects delta-5 desaturase efficiency, reducing conversion of ALA to EPA and DHA. Roughly 30 to 40% of the population carries at least one copy of the variant allele. Women with FADS1 variants convert ALA to DHA at roughly 50% the rate of those with the ancestral genotype, even when consuming high amounts of plant-based omega-3 sources. Standard prenatals typically contain ALA or a low dose of preformed omega-3, assuming conversion is normal.

During pregnancy, DHA accumulates in the fetal brain at extraordinary rates. Low DHA is linked to delayed neurodevelopment, lower IQ at birth, and impaired cognitive function. Women with FADS1 variants often discover they need 1000 to 2000 mg of preformed DHA daily, not the 200 to 300 mg in standard prenatals.

FUT2 encodes a fucosyltransferase that determines your ABO secretor status and controls the composition of glycans in your gut lining and secretions. This seemingly minor gene has outsized effects on gut bacterial composition, nutrient absorption, and B vitamin production. Non-secretors (people with certain FUT2 variants) have substantially different gut microbiomes and may absorb B vitamins less efficiently.

Common FUT2 variants affect whether you’re a secretor or non-secretor of blood group antigens. Roughly 30 to 40% of populations carry non-secretor variants. Non-secretors have reduced ability to absorb certain B vitamins from food and supplements because their gut bacterial communities produce different amounts of B vitamin metabolites. Additionally, non-secretors are more susceptible to certain nutrient-blocking pathogens and dysbiosis, which further impairs nutrient absorption.

During pregnancy, B vitamin demands are elevated for methylation, energy production, and neurological development. Non-secretor women often report persistent fatigue, B12 insufficiency, and folate deficiency despite appropriate supplementation. The problem is not the supplement; it’s that their gut microbiome composition makes B vitamin absorption fundamentally less efficient.

PPARG encodes peroxisome proliferator-activated receptor gamma, a master regulator of metabolic function, immune tolerance, and nutrient absorption. PPARG controls insulin sensitivity, mitochondrial function, and the integrity of the intestinal barrier. Variants in PPARG affect how efficiently your body absorbs and utilizes nutrients across multiple pathways.

The Pro12Ala variant in PPARG is carried by roughly 20 to 30% of populations. The Ala allele is associated with improved insulin sensitivity and metabolic flexibility, but also with slightly reduced nutrient storage capacity, meaning women with Ala alleles may need more consistent nutrient supplementation to maintain adequate status. Additionally, PPARG variants affect systemic inflammation and intestinal barrier integrity, both of which directly impact nutrient absorption.

During pregnancy, metabolic flexibility and efficient nutrient absorption become critical for accommodating the metabolic demands of fetal development and placental function. Women with certain PPARG variants often report persistent nutrient insufficiency despite supplementation, fatigue that doesn’t resolve with sleep, and slow recovery from physical exertion. The problem is often not what they’re taking, but their body’s baseline absorption and metabolic efficiency.